Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

Survey shows that depression and anxiety are reported by more than half of patients newly diagnosed with lymphoma or myeloma.

At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed ...

Low levels of soluble neuropilin-1 are associated with depression in patients with newly diagnosed type 2 diabetes, ...

Medications that help patients sleep linked to more falls, fractures, and other problems after joint procedures, a study ...

When it comes to the use of testosterone for women’s health, Australia is among the world leaders. For this interview, Rachel ...

A generative AI–powered therapy chatbot is linked to significant reductions in symptoms of depression, anxiety, and eating ...

Showing patients props and other visual aids improves recall of information, motivates patients, said doctors who have ...

Because the trial ended up being underpowered, it did not show a benefit of intensive medical treatment, but there was a high ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

A study published by the Chair for Avian Health and Biosecurity at the National Veterinary College of Toulouse, Toulouse, ...

Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone.